Indefinite Delivery Contract SPE2DX15D9362

This is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, covers a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide under the TRICARE West program.

The task orders issued to date include firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and specialized pharmaceutical items such as Botox, Xolair, Entyvio, Exparel, and Narcan. These products span various therapeutic areas including oncology, immunology, anesthesia, and substance abuse treatment. The contract has no set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure these direct federal awards. The period of performance extends through December 2025, with the primary place of performance being DMS Pharmaceutical Group's facility in Park Ridge, Illinois.